WHO
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
Published: 10/28/2026Detected: 10/28/2026
Summary preview
Prequalifies dolutegravir (sodium) API manufactured by Micro Labs Limited under WHO’s API prequalification process, enabling manufacturers of finished pharmaceutical products to select an assessed API for HIV/AIDS…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
clinical
safety
#WHO prequalification
#Active Pharmaceutical Ingredient
#API prequalification
#APIMF
#WHO GMP
Official Source Document Source Verified
Access the original document directly from WHO.
More from WHO
- Invitation to a Webinar on managing reportable changes10/28/2026
- New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices10/28/2026
- PQT/AMD newsletter - Q3 2026, Issue 54 is now available10/28/2026
- PQ Webinar: Launch of WHO Prequalification of Medical Devices10/28/2026
- VCP Updates - October 202610/28/2026